Managing Toxicities Associated With FGFR Inhibitors in Urothelial Cancer and Beyond

Decera Clinical Education Oncology Podcast · May 4, 2021 · 20m

In this episode, Ignacio Durán, MD, PhD, and Alison Birtle, MD, FRCP, FRCR, discuss toxicities associated with FGFR inhibitors used in the treatment of urothelial cancer and other malignancies

Presenters:

Ignacio Durán, MD, PhD

Associate Professor

GU Oncology Program Leader

Department of Medical Oncology

Hospital Universitario Marques de Valdecilla-Idival

Santander, Spain

Alison Birtle, MD, FRCP, FRCR

Honorary Senior Lecturer

Faculty of Health and Medicine

University of Manchester

Manchester, United Kingdom

Consultant Oncologist

Rosemere Cancer Centre

Lancashire Teaching Hospitals

Preston…